author-photo

Christine S. L. Lee

Garvan Institute of Medical Research

43

Papers

2528

Citations

Citation Trend

Filter By

Papers (43) Sort By

Journal Conference Others

Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Cyclin E1 protein is stabilized in BRCA1 mutated breast cancers leading to synergy between CDK2 and PARP inhibitors

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)
254PCyclin E1 is a shared biomarker of subsets of high grade serous ovarian cancer (HGSOC) and basal like breast cancer (BLBC)

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Mechanisms underlying uncontrolled genome doubling in breast cancer

2019
Show All
- Source
- Cite
- Save
Citations (0)
S phase dysregulation occurs following resistance to CDK4/6 inhibition ER+ breast cancer

2019
Show All
- Source
- Cite
- Save
Citations (0)
SDHD Promoter Mutations Ablate GABP Transcription Factor Binding in Melanoma

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (5)
Abstract 2240: A case series of ERBB2 indel driver mutations in non-small cell lung cancer identified by cell-free circulating tumor DNA NGS

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Cyclin E2 is the predominant E-cyclin associated with NPAT in breast cancer cells

2015 Cell Division
Show All
- Source
- Cite
- Save
Citations (16)
T-47D Breast Cancer Cells Progestin-Mediated Cell Cycle Arrest in in INK4c and p18 Kip1 Cooperation of p27

2014
Show All
- Source
- Cite
- Save
Citations (3)
9. Cyclin-Dependent kinase inhibitor as a potential novel therapeutic agent for pancreatic cancer

2014 Pathology
Show All
- Source
- Cite
- Save
Citations (0)